Study of MEDI-547 to Evaluate the Safety, Tolerability, and Biologic Activity of IV Administration in Subjects With Relapsed or Refractory Solid Tumors
This study has been terminated.
( MI-CP177 study closed per sponsor decision. )
Study NCT00796055
Information provided by MedImmune LLC
First Received on November 20, 2008.
Last Updated on November 16, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
